Cervical cancer prevention – programme managers meet in Istanbul to strengthen decision-making and share experiences and best practice

In the European Region more than 30 000 women die from cervical cancer each year - a disease which is largely avoidable.

A comprehensive approach comprising of immunization, organized screening, and early treatment, is necessary to reduce the incidence of, and mortality from, cervical cancer, which is almost entirely caused by the human papillomavirus (HPV). The recent introduction of HPV vaccines and organized cervical cancer screening requires forming new partnerships at international and national levels throughout a wide range of sectors, ranging from vaccines, adolescent and women’s health to sexual and reproductive health and rights, and cancer control.

More than 40 Member States will meet in Istanbul to review progress and share experience, best practices and lessons learned within cervical cancer prevention. The meeting will take place 11-12 October 2011.